Shandong Sinoglory Health Capital Reinvestment Ratio

Latest as of December 2025: 0.69x

Shandong Sinoglory Health capital reinvestment ratio. Shandong Sinoglory Health (603182) has a Capital Reinvestment Ratio of 0.69x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥79.36 Million) in capital expenditures (CN¥54.75 Million). Check how aggressively does Shandong Sinoglory Health reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.69x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥79.36 Million
CNY

Capital Expenditures

CN¥54.75 Million
CNY

Data as of

Dec 2025
Most recent filing

Capital Reinvestment Ratio of Shandong Sinoglory Health (2020–2025)

Capital reinvestment ratio of Shandong Sinoglory Health from 2020 to 2025. This chart tracks Shandong Sinoglory Health's Capital Reinvestment Ratio across 6 annual periods. Also explore net asset momentum of Shandong Sinoglory Health to track the company's year-over-year net asset growth rate.

Shandong Sinoglory Health Capital Reinvestment Ratio by Year (2020–2025)

Shandong Sinoglory Health capital reinvestment ratio by year from 2020 to 2025. For the full cash flow conversion analysis, see how efficiently does Shandong Sinoglory Health generate cash.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.69x CN¥79.36 Million CN¥54.75 Million ▼ -45.8%
2024 1.27x CN¥313.81 Million CN¥399.54 Million ▼ -69.3%
2023 4.15x CN¥37.34 Million CN¥154.79 Million ▲ +899.3%
2022 0.41x CN¥109.17 Million CN¥45.29 Million ▼ -46.6%
2021 0.78x CN¥43.34 Million CN¥33.70 Million ▲ +20.0%
2020 0.65x CN¥109.73 Million CN¥71.10 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow